Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

(Harare, Zimbabwe, all races, 1993-1997 cases* followed-up until 1999)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	No. of cases	Male			Female			Number of cases by age group					Relative survival by age group
			5-year survival			5-year survival			Number of cases by age group					Relative survival by age group
			No.	Abs	Rel	No.	Abs	Rel	<45	45-54	55-64	65-74	75+	<45	45-54	55-64	65-74	75+
C15	Oesophagus	131	121	9.4	11.6	10	20.0	25.7	19	32	40	25	15	21.3	10.9	11.9	10.5	12.6
C16	Stomach	129	79	17.6	22.4	50	19.0	22.9	18	22	43	33	13	23.5	25.7	27.6	15.8	0.0
C18	Colon	57	47	20.2	26.5	10	10.0	12.6	9	11	13	15	9	12.8	21.0	37.0	31.9	0.0
C19-20	Rectum	67	25	29.4	37.8	42	16.3	20.5	13	12	22	12	8	25.7	12.0	10.6	64.9	71.0
C22	Liver	132	132	2.9	3.7				34	25	29	31	13	10.0	0.0	0.0	0.0	0.0
C32	Larynx	73	64	24.6	33.9	9	12.7	15.8	10	12	17	23	11	22.9	21.6	19.6	52.1	26.2
C33-34	Lung	116	94	9.6	12.2	22			14	21	35	37	9	8.3	16.5	12.9	7.7	19.4
C43	Melanoma skin	101	51	61.6	78.1	50	69.9	83.4	29	26	24	13	9	93.0	69.2	82.5	54.3	104.9
C46	Kaposi sarcoma	151	110	5.0	5.3	41	6.5	7.3	147	4	0	0	0	5.2	0.0	0.0	0.0	0.0
C50	Breast	258	5	100.0	149.9	253	50.3	61.9	70	69	51	37	31	51.2	62.2	52.8	66.9	122.8
C53	Cervix	264				264	34.3	39.9	109	67	52	27	9	41.5	40.5	24.8	49.2	76.5
C56	Ovary	63				63	31.4	36.8	27	12	14	7	3	30.4	39.4	56.5	0.0	64.4
C61	Prostate	64	64						0	2	11	31	20	0.0	0.0	0.0	0.0	0.0
C67	Urinary bladder	130	96	31.2	43.7	34	24.8	31.6	22	22	37	28	21	34.0	15.7	22.7	61.4	88.7
C69	Eye	116	57	48.7	55.4	59	65.2	73.6	99	10	3	3	1	63.7	90.6	0.0	134.2	0.0
C81	Hodgkin lymphoma	39	23	43.8	46.9	16	50.0	56.2	35	3	1	0	0	50.4	73.9	0.0	0.0	0.0
C82-85+C96	Non-Hodgkin lymphoma	99	73	19.0	22.9	26	21.6	24.9	63	19	12	3	2	17.7	19.8	0.0	42.1	246.1

Graphs:

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)
- Table2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)
- Table4:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Harare, Zimbabwe, all races, 1993-1997 cases* followed-up until 1999)

Registry chapter: